by Cort Johnson | Oct 10, 2018 | CDC, Definition, Diagnosis, Exercise, HPA axis, Inflammation, Klimas, Mifepristone
Roundtable The Centers for Disease Control (CDC) flew in about 40 people from over two dozen organizations for the one-day CDC Roundtable on Medical Education and ME/CFS. It was a busy 24 hours. Everyone flew in the night before to a hotel near the airport, spent the... 
by Cort Johnson | Oct 3, 2018 | Autoimmune, Energy Production, Homepage, Human Herpes Virus Six (HHV-6), Immune, Neuroinflammation
As we know, grant applications in chronic fatigue syndrome (ME/CFS) are hard to come by. Freedom of Information Requests indicate that the NIH received the lowest number of ME/CFS grant applications in memory last year – just 15. Since the NIH spends MUCH more... 
by Cort Johnson | Oct 1, 2018 | Immune, Lyme Disease (Borrelia), Research
Why some people with Lyme disease fail to recover after antibiotic treatment is a question that touches not only on them but on other commonly post-infectious illnesses like ME/CFS, FM and POTS. Further work is needed but an answer could be at hand. Not only did a... 
by Cort Johnson | Sep 30, 2018 | Brain, Herbs and Botanicals, Immune, Mast cell activation syndrome
Theoharis Theoharides believes that metabolic problems are present in ME/CFS but he has a new idea why they’re occurring. In a hypothesis where mast cells meet the brain, Theoharides proposes that mast cells in the hypothalamus are pouring out neuro-inflammatory... 
by Cort Johnson | Sep 25, 2018 | Brain, Homepage, Inflammation, Neuroinflammation, Neuroinflammation, T-cells
Breaches in the Barrier The last article reported that Younger speculated that people with chronic fatigue syndrome (ME/CFS) have an immune-triggered metabolic disorder. The widespread neuroinflammation found in ME/CFS patients provides a clue, he thinks, to... 
by Cort Johnson | Sep 13, 2018 | Autoimmune, Fibromyalgia, Homepage, IVIG, Klimas, Levine, POTS, Treatment
“The bottom line is that we should rethink this whole area and encourage proper clinical trials.” Dr. Nancy Klimas This article is the last of a three-part series on IVIG which came out of my attending the 2018 Dysautonomia Conference in Nashville, Tennessee. An IVIG...
